303 related articles for article (PubMed ID: 9439759)
1. Myasthenia gravis as a prototype autoimmune receptor disease.
Hoedemaekers AC; van Breda Vriesman PJ; De Baets MH
Immunol Res; 1997; 16(4):341-54. PubMed ID: 9439759
[TBL] [Abstract][Full Text] [Related]
2. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis: an autoimmune response against the acetylcholine receptor.
Graus YM; De Baets MH
Immunol Res; 1993; 12(1):78-100. PubMed ID: 7685805
[TBL] [Abstract][Full Text] [Related]
4. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
5. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis, a model of organ-specific autoimmune disease.
Berrih-Aknin S
J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
[TBL] [Abstract][Full Text] [Related]
8. Disorders affecting the acetylcholine receptor: myasthenia gravis and congenital myasthenia.
Vincent A
J Recept Res; 1987; 7(1-4):599-616. PubMed ID: 2442386
[TBL] [Abstract][Full Text] [Related]
9. [Clinical correlation of anti-receptor antibody titer, sensitivity to curare and electromyographic changes in experimental autoimmune myasthenia gravis].
Chen SM
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):293-6, 320. PubMed ID: 2282884
[TBL] [Abstract][Full Text] [Related]
10. The immunopathology of myasthenia gravis.
Lennon VA
Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
[TBL] [Abstract][Full Text] [Related]
12. Cytophilic antibodies in experimental autoimmune myasthenia gravis.
Martinez RD; Tarrab-Hazdai R; Aharonov A; Fuchs S
J Immunol; 1977 Jan; 118(1):17-20. PubMed ID: 830746
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?
Baggi F; Antozzi C; Toscani C; Cordiglieri C
Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):19-30. PubMed ID: 22159475
[TBL] [Abstract][Full Text] [Related]
14. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
Verschuuren JJ; Spaans F; De Baets MH
Muscle Nerve; 1990 Jun; 13(6):485-92. PubMed ID: 2366822
[TBL] [Abstract][Full Text] [Related]
15. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
Graus YM; Verschuuren JJ; Spaans F; Jennekens F; van Breda Vriesman PJ; De Baets MH
J Immunol; 1993 May; 150(9):4093-103. PubMed ID: 8386206
[TBL] [Abstract][Full Text] [Related]
16. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
17. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease.
Moiola L; Galbiati F; Martino G; Amadio S; Brambilla E; Comi G; Vincent A; Grimaldi LM; Adorini L
Eur J Immunol; 1998 Aug; 28(8):2487-97. PubMed ID: 9710226
[TBL] [Abstract][Full Text] [Related]
18. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis.
Yang B; McIntosh KR; Drachman DB
Clin Immunol Immunopathol; 1998 Jan; 86(1):45-58. PubMed ID: 9434796
[TBL] [Abstract][Full Text] [Related]
19. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
Pachner AR; Kantor FS
Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
